Humana Inc（HUM）のニュースとイベントHUMHumana Inc

Humana Forms New Joint Venture with BlackRock

Humana (HUM) announced it has entered into a new joint venture agreement with funds and accounts managed by HPS Investment Partners, a part of BlackRock (BLK), to manage and operate an existing network of nearly 150 CenterWell Senior Primary Care clinics that currently sit within joint ventures owned by funds affiliated with WCAS and CenterWell. The new joint venture, majority owned by BlackRock and minority owned by CenterWell, will replace the current CenterWell and WCAS joint ventures that were instrumental in successfully scaling CenterWell into the nation's largest provider of senior-focused value-based primary care over the last seven years. The new joint venture is expected to support future growth opportunities for CenterWell, while also unlocking additional growth capital and providing greater financial flexibility for Humana. BlackRock, one of the world's leading investment management firms, complements this strategy by delivering substantial capital at scale, along with deep expertise in private financing. This is Humana's second strategic transaction with BlackRock this year, following Humana's announcement that it has signed a definitive agreement to divest all or substantially all of its minority interest in Gentiva to a consortium of investors, including BlackRock. As part of the transaction, BlackRock will acquire WCAS's current equity ownership, valued at approximately $2.8B, with modifications to terms reflecting the maturity of the business today compared to when the legacy joint ventures were formed. Over the next two years, the new joint venture is expected to deploy additional capital that will be used to fund existing clinical operations, establish new clinics, and expand the network through strategic acquisitions. CenterWell will continue to manage the operations at all clinics owned by the new joint venture, delivering uninterrupted, high-quality care to its patients. Beginning in 2028, CenterWell will have the option to purchase clinics from the joint venture at its election. If CenterWell has not acquired all of the joint venture's clinics by the end of 2033, BlackRock will have the right to exit the joint venture through a sale process for the joint venture's remaining clinics, subject to CenterWell's right to submit the first offer to acquire any such remaining clinics. Since the new joint venture does not include a put option, Humana expects a significant reduction in the liabilities on its balance sheet due to the removal of the put arrangements for the existing joint ventures, with BlackRock receiving certain protections. All in, Humana anticipates a significantly lower cost of capital under the new joint venture, reflecting the maturity of the business. The transaction is expected to close in the fourth quarter of 2026, subject to customary closing conditions and state and federal regulatory approval, and is not expected to have a material impact on Humana's 2026 adjusted earnings guidance.

Trump Says U.S. Will Not Strike Iran, Oil Pulls Back

Bets on a solid earnings season sent stocks to within striking distance of their all-time highs and oil pulled back as President Trump said that the U.S. will not resume military strikes against Iran before the November midterm elections. In addition, Trump said late in the session that Russian leader Vladimir Putin had agreed to release diesel supplies into the global market.The corporate earnings test begins next week, with reports due from JPMorgan, Bank of America, Citigroup, Johnson & Johnson, and UnitedHealth.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:SpaceXwill acquire a nationwide low-band spectrum license portfolio of up to 14 megahertz of paired spectrum in the 800 MHz band as part of efforts to help Starlink Mobile become a "major mobile carrier" in the U.S.Humanashares jumped while Alignment Healthcareslipped after the Centers for Medicare & Medicaid Services published its 2027 Medicare Part C and Part D Star RatingsDeltareported mixed Q3 results and cut its FY26 earnings outlookApplehas asked some of its suppliers to cut production of components for its iPhone 18 Pro and iPhone 18 Pro Max, Nikkei Asia reportsLumentumCEO Michael Hurlston said the company has "completely sold out" in its optoelectronics parts through nearly 2029, Bloomberg reports2. WALL STREET CALLS:Scotiabank upgraded Webullto Outperform on valuationPershing Squaredowngraded to Sell at Citi after share rallyMonness upgraded Elasticto Buy on agentic AI trendsAlignment Healthcaredowngraded to Neutral at BofAOppenheimer upgraded Fastlyto Outperform on solid industry checks, agentic AI opportunity3. AROUND THE WEB:Hunterbrook is short Meta, saying data show that Muse downloads are slowingCable Oneis close to closing a $1.25B first-lien financing deal, WSJ reportsSouthwestis leaning toward Boeing's787 Dreamliner as its first widebody aircraft to support potential long-haul international expansion, though no final decision has been made and approval rests with the board, Reuters reportsChina-made Teslavehicles were up 5% from a year ago in September, an increase from a 3.6% gain in August, Reuters saysCarlyleis no longer actively pursuing a deal to acquire international assets of Lukoil, Reuters reports4. MOVERS:Quantum-Sigained after announcing it demonstrated detection of 19 amino acids in its Proteus development programGinkgo Bioworksrose after announcing it will provide autonomous lab access to NSF X-Labs researchersModernasurged after the New York Times reported that that NIH is making a big bet on a public-private partnership over cancer vaccinesBrookdale Senior Livingwas lower after announcing occupancy for SeptemberJoby Aviationfell after Barclays downgraded the stock to Underweight5. EARNINGS/GUIDANCE:Braema Hotels & Resortsprovided guidance for FY27Park Aerospacereported Q2 results, with EPS and revenue higher year-over-yearOil-Dri Corporation of Americareported Q4 results, with Daniel Jaffee commenting the company reported its "strongest full year sales" in its historyJPMorganto report Q3 results on October 13Johnson & Johnsonto report Q3 results on October 13INDEXES:The Dow rose 423.31, or 0.83%, to 51,654.95, the Nasdaq gained 172.83, or 0.64%, to 27,366.17, and the S&P 500 advanced 46.18, or 0.59%, to 7,811.54.

Humana Stock Rises 12.8% to $436.60

Humana is up 12.8%, or $49.48 to $436.60.